MSH SEP 2025 FELLOWSHIP PART 2 EXAM

Malaysian Society of Haematology – Part 2 Viva Exam (2025)

The Part 2 Viva Examination will be held on 18th September 2025

Venue:  Department of Internal Medicine, Sultan Ahmad Shah Medical Centre @ IIUM, Kuantan.

Eligibility Criteria:

  • Completion of 3 years of Haematology training

  • Obtained supervisor’s approval and report

  • Passed Part 1 examination

  • Completed dissertation successfully or have a publication

Important Deadlines:

  • Application form submission: by 18th August 2025

  • Logbook and thesis submission to the training committee: by 18th August 2025

  • Exam registration fee (RM 200) must be paid before the exam date

HEMON Update 13-15 June 2025

HEMON Update 13-15 June 2025

On behalf of the Organizing Committee of the Semarang Hematology Medical Oncology (HEMON) Update 2025, we kindly invite your organization to participate in and support the promotion of this upcoming scientific event, which will be held in Semarang, Indonesia, from June 13–15, 2025, in a hybrid format (onsite and online).
 
This event will include symposia, plenary lectures, workshops, and case discussions, highlighting the latest advances in cancer care, targeted therapy, immunotherapy, and the integration of digital and precision medicine in clinical oncology.
 
Further information on the program and registration is available in the attached brochure and
EBMT 2024 Springer Nature Best Clinical Poster Award

EBMT 2024 Springer Nature Best Clinical Poster Award

Congratulations to Dr. Wong Shu Ping and Team from Hospital Ampang

Join us in honoring Dr. Wong Shu Ping and her team from Hospital Ampang for winning the EBMT award with their poster titled:


"THE IMPACT OF ORAL AND GUT MICROBIOTA WITH CONSIDERATION OF CLINICAL AND IMMUNOLOGICAL FACTORS ON MUCOSITIS OUTCOMES: AN ASIAN HAEMATOPOIETIC STEM CELL TRANSPLANT POPULATION."  

Dr. Wong Shu Ping received the MSH educational grant (travel) to attend the EBMT 2024 conference, held in Glasgow from 14–17 April.

We applaud her dedication and are proud to celebrate the team’s outstanding contribution to research and patient care.

Link to EMBT News